UMIN000051670
A multicenter retrospective observational study to evaluate the efficacy and safety of durvalumab following concurrent chemoradiotherapy for stage III non-small cell lung cancer harboring EGFR mutation (NEJ063 study)
Tohoku University Hospital·Not Applicable·University Hospital Medical Information NetworkNot yet recruiting
Study focus
- Disease/Condition
- Non-small cell lung cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Tohoku University Hospital
- Location
- Japan
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Sep 30, 2023
- End date
- N/A
ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000051670
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000051670 through Pure Global AI's free database. This Not Applicable trial is sponsored by Tohoku University Hospital and is currently Not yet recruiting. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.